Maitreya Medicare Ltd

Maitreya Medicare Ltd

₹ 160 -0.93%
24 May - close price
About

Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]

Key Points

Integrated Healthcare Provider[1] Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.

  • Market Cap 108 Cr.
  • Current Price 160
  • High / Low 229 / 114
  • Stock P/E 25.6
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 32.8 %
  • ROE 63.2 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Debtor days have increased from 55.2 to 90.4 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Sep 2023 Dec 2023
8.59 14.05 11.72
8.29 10.99 9.21
Operating Profit 0.30 3.06 2.51
OPM % 3.49% 21.78% 21.42%
0.15 0.04 0.03
Interest 0.14 0.13 0.13
Depreciation 0.34 0.32 0.32
Profit before tax -0.03 2.65 2.09
Tax % 0.00% 20.00% 24.40%
-0.02 2.13 1.58
EPS in Rs -20.00 4.29 2.33
Raw PDF
Upcoming result date: 28 May 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
55.93 49.35 39.28
48.68 45.98 32.05
Operating Profit 7.25 3.37 7.23
OPM % 12.96% 6.83% 18.41%
0.43 0.33 0.57
Interest 0.82 0.78 0.60
Depreciation 1.09 1.32 1.29
Profit before tax 5.77 1.60 5.91
Tax % 26.52% 28.75% 28.43%
4.24 1.14 4.23
EPS in Rs 4,240.00 1,140.00 8.53
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -20%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 291%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 63%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0.01 0.01 4.96 10.70
Reserves 3.85 4.70 3.68 6.37
Preference Capital 5.05 4.88 5.74
9.19 7.50 5.85 5.21
12.22 12.28 13.01 10.89
Total Liabilities 25.27 24.49 27.50 33.17
13.84 13.40 11.60 11.00
CWIP 0.00 0.00 0.00 0.00
Investments 1.07 0.32 0.68 0.78
10.36 10.77 15.22 21.39
Total Assets 25.27 24.49 27.50 33.17

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
4.45 0.08 1.64
-5.07 -0.02 0.31
2.16 -1.86 -1.61
Net Cash Flow 1.55 -1.80 0.34

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
Debtor Days 31.91 43.42 90.41
Inventory Days 68.78 40.82 69.86
Days Payable 258.06 221.84 319.59
Cash Conversion Cycle -157.37 -137.61 -159.32
Working Capital Days 3.65 12.28 55.66
ROCE % 12.33% 32.80%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2024
73.11%
2.53%
1.35%
23.02%
No. of Shareholders 474

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents